Alemtuzumab’s Long Term Studies About Efficacy for MS Treatment
In this MD Magazine TV video, learn how alemtuzumab, also known as Lemtrada, has proven to be an effective treatment option for multiple sclerosis.
Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.